A4F, iBET, LNEG, IMIC CAS, PhyCom, For Farmers, International Flavors & Fragrances, Upfield
MULTI-STR3AM – Towards Industrial-scale Microalgae Cultivation in Europe
Horizon 2020
May 01, 2020
— April 30, 2025
Projects
iBET has been involved in some of the most prestigious RD&I and technology transfer projects, with remarkable impact internationally at many scientific and technological domains.
Filters
Navarra Univ., Zaragoza Univ., EBERS, SaludMadrid, PNO, Leartiker S. Coop, IBEC, Eindhoven Univ., UMC Utrecht, AE Medicalis, KU Leuven, Univ. Hospital Würzburg, Boston Scientific
BRAV3 – A Cardiac Regenerative Medicine European Initiative
European Comission
October 01, 2020
— June 30, 2025
iBET Biofarma Building – Technological Infrastructure
Portugal2020, Lisboa2020, European Union
December 20, 2022
— August 31, 2023
GreenPlantFood – Green technology for plant-based food
Norwegian Research Council
April 01, 2021
— March 01, 2025
Nine Partners from Spain, Portugal and France
CARDIOPATCH: Development of Advanced Therapies of Myocardial Infarction Treatment based on Regenerative Medicine and 3D Printing
Interreg SUDOE Programme - European Regional Dev. Fund
September 01, 2020
— September 01, 2023
PRINTƎD – AAV PRocess INTensification with 3D printed materials
Fundação para a Ciência e Tecnologia
January 01, 2022
— June 30, 2023
CARTool – A process engineering approach for manufacturing CAR T cells in biOreactOrs with improved cLinical revelance
FCT - Fundação para a Ciência e Tecnologia
March 01, 2023
— December 31, 2024
University of Bristol, Liverpool School of Tropical Medicine, Liége Université, Aix Marseille Université
ADDovenom – Novel Snakebite Therapy Platform of Unparalleled Efficacy, Safety and Affordability
European Comission
October 01, 2020
— September 30, 2024
SafeFood – Evaluate the effectiveness and effects of ultraviolet light‐emitting diodes for food production, preservation, and microbiological safety
FCT - Fundação para a Ciência e a Tecnologia
March 12, 2023
— September 11, 2024
INIAV, ITQB NOVA, Casa do Arroz, Ernesto Morgado, Mater Dynamics, BGI, Grupo Desarrollo, IATA, Alexandria Univ.
TRACE-RICE – Tracing Rice and Valorizing Side Streams along Mediterranean Blockchain
European Comission
March 12, 2020
— April 11, 2024
Concluded Projects (Previous to 2020)
- CARDIOCONTRACT: Automated Cardiomyocyte Contractility Assay Instrument.
2018-2020, EUROSTARS-2 – 12529/19/Q - DiViNe – Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies: novel affinity ligands and biometric membranes.
2015-2019, H2020-LEIT-BIO-1-635770. Funded by the EU - INNOVATE – Investigating the Novel Valuable bio-therapeutics and expression systems.
2014-2017, ERA-IB-2/0007/2013, Funded by the EU - EDUFLUVAC – Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure.
2013-2017, FP7-HEALTH-2013-INNOVATION. Funded by the EU. - EPIGENESIS – One Health approach to integrate Guadeloupe research on vector-borne and emerging diseases in the ERA.
2013-2016, FP7-REGPOT-2012-2013-1, funded by the EU. - BRAINVECTORS— From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV.
2012-2016, FP7-PEOPLE-2011-IAPP. Funded by the EU. - SpeCCC – Specialised Cell Carrier Components.
2012-2015, FP7‐SME‐2012‐315717. Funded by the EU - NanoGene – Stem cell generation and manipulation by nanoparticle mediated gene transfer for the safe clinical application of gene-modified cells.
2011-2014, ENMED/0001/2010, funded by EuroNanoMed ERA-Net. - PREDECT – New Models for Preclinical Evaluation of Drug Efficacy in common solid tumours.
2011-2016, GRANT AGREEMENT No. 115188, funded by IMI (Innovative Medicines Initiative) Joint Undertaking, funded by EU. - ComplexINC – New Technologies and Production Tools for Complex Protein Biologics.
2011-2015, FP7 / SME-targeted research for developing tools and technologies for high-throughput research, funded by EU. - CAREMI – Cardio Repair European Multidisciplinary Initiative.
2010-2015, HEALTH-F5-2010-242038, funded by EU - HYPERLAB – high yield and performance stem cell lab.
2009-2012, funded by EU (223011) - BrainCAV: Gene Transfer for Brain Therapy.
2008-2012, funded by EU (FP7-222992) - CLINIGENE-NoE: European Network for the Advancement of Clinical Gene Transfer and Therapy.
2006-2011, LSHB-CT-2006-018933, funded by the EU - VITROCELLOMICS – Reducing Animal Experimentation in Preclinical Predictive Drug Testing by Human Hepatic in vitro Models Derived from Embryonic Stem Cells.
2006-2009, funded by EU (LSHB-CT-2006-018940) - BACULOGENES – Baculovirus Vectors for Gene Therapy.
2006-2009, FP6 – 2007, funded by the EU - MARKVAC – Development of marker vaccines, companion diagnostic tests and improvement of epidemiological knowledge to facilitate control of rinderpest and peste des petits ruminants viruses.
2005-2007, RP/PPR MARKVAC, funded by the EU - EPIGENEVAC – Epidemiology and new generation vaccines for Ehrlichia and Anaplasma infections of ruminants.
2005-2009, FP6-003713-INCO-DEV-1, funded by the EU - CELLPROM – Cell Programming by Nanoscaled Devices.
2004-2009, NMP4-CT-2004-500039, funded by the EU - INSERTAGENE – Integrated Strategies for efficient therapeutic retrovirus based on modular cell lines.
2003-2005, QLK3-CT-2002-01949, funded by the EU - ROTASAFE – Novel strategies for a safe rotavirus vaccine.
2003-2005, QLRT-2001-01249, funded by the EU - COWDRIA – Mass production of Cowdria ruminantium to produce a cost effective veterinary vaccine against heartwater.
2001-2004, 8-ACP-TPS-040, funded by the EU - ORALVAC – Development of Oral Vaccines, Role of Wildlife in The Maintenance of these Diseases.
2001-2004, ICA4-CT-2000-30027, funded by the EU
- ERAdicatPH: Understanding primary hyperoxaluria type 1 towards the development of innovative therapeutic strategies.
2016-2019, E-Rare3/0002/2015, funded by FCT, Portugal - Therapeutic Targets for Triple Negative Breast Cancer: Development of mono and bispecific antibodies against Notch1 ligands.
2016-2019, PTDC/BBB-BMD/4497/2014, funded by FCT, Portugal - NETDIAMOND: New targets in diastolic heart failure: from comorbidities to personalized medicine.
2016-2019, POCI-01-0145-FEDER-016385 - CardioRegen: Integrative studies from the embryo to Scalable Multipronged Generation of hESC-derived Myocardial progenitors for heart repair.
2015-2019, HMSP-ICT/0039/2013, HMS program, funded by FCT, Portugal - Engineering biosensors for human cell type and state diagnosis using synthetic digital computation.
2018-2019, MIT-EXPL/BIO/0097/2017 - Establishment of a flexible insect cell platform for fast production of pseudo-typed VLPs for drug and vaccine development.
2014-2015, EXPL/BBB-BIO/1541/2013, funded by FCT, Portugal - Molecular approaches to develop an insect cell production system for Hepatitis C vaccine candidate.
2014-2015, EXPL/BBB-BIO/1129/2013, funded by FCT, Portugal - Development of a scalable strategy for stem cells purification.
2013-2014, EXPL/BBB-EBI/1003/2012, funded by FCT, Portugal. - Systems biotechnology for improved production of biopharmaceuticals in animal cells.
2013-2015, PTDC/BBB-BSS/0518/2012, funded by FCT, Portugal. - Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation.
2013-2015, PTDC/BBB-BIO/1240/2012, funded by FCT, Portugal. - Integrative approaches to depict human cardiac stem cell receptome and its role in the cardiac regenerative process.
2013-2015, PTDC/BBB-BIO/1414/2012, funded by FCT, Portugal. - A novel generation of packaging cell lines for the manufacture of lentivirus based biopharmaceuticals.
2012-2015, PTDC/EBB-BIO/118615/2010, funded by FCT, Portugal. - Development of improved suspension MDCK cell lines for the production of viral based bioproducts: manufacturing Influenza and Adenovirus.
2012-2015, PTDC/EBB-EBI/118621/2010, funded by FCT, Portugal. - Human central nervous system in vitro models for preclinical research: new tools for studying viral vector-mediated gene.
2012-2015, PTDC/EBB-BIO/119243/2010, funded by FCT, Portugal. - Probing adenovirus-host cell interactions: a systems biotechnology approach to improve production of gene delivery vectors.
2012-2015, PTDC/EBB-BIO/119501/2010, funded by FCT, Portugal. - Development of function blocking antibodies using Phage Display Technology: Inhibiton of the Notch1 signaling pathway by function blocking anti-jagged 1 antibody.
2012-2016, PTDC/SAU-ONC/121670/2010, funded by FCT, Portugal - MSVida: The architecture of life – Probing the quaternary structure of virus capsids by native mass spectrometry.
2012-2016, RECI/BBB-BEP/0104/2012, funded by FCT, Portugal - 3D in vitro models for reducing animal experimentation in pharmaceutical development: integrative approaches for prediction of hepatic drug metabolism and neurotoxicity.
2011-2014, PTDC/EBB-BIO/112786/2009, funded by FCT, Portugal. - Preconditioning triggered by Carbon monoxide: new strategies to prevent brain damage due to hypoxia-ischemia and reperfusion.
2010-2012, PTDC/SAU-NEU/098747/2008, funded by FCT, Portugal. - 2D fluorometry: a powerful tool to improve mammalian cell process development.
2010-2012, PTDC/EBB-EBI/102750/2008, funded by FCT, Portugal. - Novel Cell Factories for the production of secreted complex bioproducts: a syntetic biology approach for improved product Stoichiometries.
2010-2012, PTDC/EBB-EBI/102266/2008, funded by FCT, Portugal. - BACULOME-Engineering cellular energetics for improvement of bioprocesses: metabolic modeling for enhanced vaccines production.
2010-2012, PTDC/EBB-EBI/103359/2008, funded by FCT, Portugal. - Retroviral like particles: improving potential as candidate vaccines for Hepatitis C.
2010-2012, PTDC/EBB-BIO/102649/2008, funded by FCT, Portugal. - Using functional genomics to improve mammalian cells for virus based biopharmaceuticals manufacture.
2010-2012, PTDC/EBB-BIO/100491/2008, funded by FCT, Portugal. - Integrated strategies for expansion, neuronal differentiation and cryopreservation of human embryonic stem cells.
2009-2012, funded by FCT (PTDC/BIO/72755/2006) - Fundamentals of downstream processing of enveloped viruses: towards an integration of purification processes.
2007-2010, funded by FCT (PTDC/EQU-EQU/71645/2006) - Manufacturing canine adenovirus vectors for gene therapy: development of MDCK CAV-2E1- transcomplementing cell lines.
2007-2010, funded by FCT (PTDC/BIO/69452/2006) - Development of flexible cell lines for the Production of Retrovirus and Lentivirus for Gene Therapy.
2007-2010, funded by FCT (PTDC/BIO/69451/2006) - Novel stroke model for neuroprotective research: bioreaction of primary brain cell aggregates.
2007-2010, funded by FCT (PTDC/BIO/69407/2006) - Carbon monoxide as a neuroprotective agent against hypoxia-ischemia and reperfusion.
2007-2010, funded by FCT, Portugal (PTDC/SAU-NEU/64327/2006) - Advanced Control of BHK Cultivation Processes Based on Intracellular Metabolic Fluxes.
2005-2007, funded by FCT, Portugal (POCI/BIO/57927/2004) - THERAVECT – Production, Purification and Storage of Retroviral Vectors Produced by Modular Master Producer Cells.
2005-2007, funded by FCT, Portugal (010.6/A003/2005) - CELL CRYOTHERA – Cell Cryopreservation for Therapy and Regenerative Medicine.
2005-2007, funded by FCT, Portugal (010.6/A006/2005) - Genetics, Stoicheometry and Kinetics of Multiple Protein Assembly: the case for a Rotavirus Like Particle.
2005-2007, funded by FCT (POCTI/BIO/55975/2004) - Integrated strategy for the production, purification and storage of adenovirus.
2004-2006, funded by FCT, Portugal (POCTI/BIO/46515/2002) - Metabolic Trafficking between neurons and astrocytes under stress conditions implicated in neurological disorders.
2003-2006, funded by FCT, Portugal (POCTI/BIO/39214/2001) - Stabilization of retroviruses for gene therapy clinical applications.
2001-2003, funded by FCT, Portugal (POCTI/BIO/35695/2000) - Cell cycle control for better biotechnological methods in therapeutic protein production.
2001-2003, funded by FCT, Portugal (POCTI/BIO/35687/2000)